208 related articles for article (PubMed ID: 18245814)
21. Expression of CYLD, NF-kappaB and NF-kappaB-related factors in salivary gland tumors.
Fukuda M; Fukuda F; Horiuchi Y; Oku Y; Suzuki S; Kusama K; Sakashita H
In Vivo; 2006; 20(4):467-72. PubMed ID: 16900776
[TBL] [Abstract][Full Text] [Related]
22. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB.
Brummelkamp TR; Nijman SM; Dirac AM; Bernards R
Nature; 2003 Aug; 424(6950):797-801. PubMed ID: 12917690
[TBL] [Abstract][Full Text] [Related]
23. CYLD suppression enhances the pro-inflammatory effects and hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes by enhancing NF-κB activation.
Zhang LM; Zhou JJ; Luo CL
Arthritis Res Ther; 2018 Oct; 20(1):219. PubMed ID: 30285829
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of CYLD downregulation in breast cancer.
Hayashi M; Jono H; Shinriki S; Nakamura T; Guo J; Sueta A; Tomiguchi M; Fujiwara S; Yamamoto-Ibusuki M; Murakami K; Yamashita S; Yamamoto Y; Li JD; Iwase H; Ando Y
Breast Cancer Res Treat; 2014 Feb; 143(3):447-57. PubMed ID: 24398777
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H
Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933
[TBL] [Abstract][Full Text] [Related]
26. Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling.
Massoumi R; Chmielarska K; Hennecke K; Pfeifer A; Fässler R
Cell; 2006 May; 125(4):665-77. PubMed ID: 16713561
[TBL] [Abstract][Full Text] [Related]
27. Optineurin is required for CYLD-dependent inhibition of TNFα-induced NF-κB activation.
Nagabhushana A; Bansal M; Swarup G
PLoS One; 2011 Mar; 6(3):e17477. PubMed ID: 21408173
[TBL] [Abstract][Full Text] [Related]
28. CYLD regulates RhoA activity by modulating LARG ubiquitination.
Yang Y; Sun L; Tala ; Gao J; Li D; Zhou J; Liu M
PLoS One; 2013; 8(2):e55833. PubMed ID: 23405219
[TBL] [Abstract][Full Text] [Related]
29. Inflammation-related induction of absent in melanoma 2 (AIM2) in vascular cells and atherosclerotic lesions suggests a role in vascular pathogenesis.
Hakimi M; Peters A; Becker A; Böckler D; Dihlmann S
J Vasc Surg; 2014 Mar; 59(3):794-803. PubMed ID: 23790454
[TBL] [Abstract][Full Text] [Related]
30. Deubiquitinases in the regulation of NF-κB signaling.
Harhaj EW; Dixit VM
Cell Res; 2011 Jan; 21(1):22-39. PubMed ID: 21119682
[TBL] [Abstract][Full Text] [Related]
31. Loss of CYLD might be associated with development of salivary gland tumors.
Fukuda M; Hiroi M; Suzuki S; Ohmori Y; Sakashita H
Oncol Rep; 2008 Jun; 19(6):1421-7. PubMed ID: 18497946
[TBL] [Abstract][Full Text] [Related]
32. Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling.
Blake PW; Toro JR
Hum Mutat; 2009 Jul; 30(7):1025-36. PubMed ID: 19462465
[TBL] [Abstract][Full Text] [Related]
33. The tumor suppressor CYLD regulates entry into mitosis.
Stegmeier F; Sowa ME; Nalepa G; Gygi SP; Harper JW; Elledge SJ
Proc Natl Acad Sci U S A; 2007 May; 104(21):8869-74. PubMed ID: 17495026
[TBL] [Abstract][Full Text] [Related]
34. Uncoupling Protein 2 Inhibits Myointimal Hyperplasia in Preclinical Animal Models of Vascular Injury.
Zhang Y; Zhang Y; Li W; Wang P; Gu R; Feng Y; Wei S; Peng K; Zhang Y; Su L; Wang Q; Li D; Yang D; Wong WT; Yang Y; Ma S
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29025747
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-24 Attenuates Neointimal Hyperplasia in the Diabetic Rat Carotid Artery Injury Model by Inhibiting Wnt4 Signaling Pathway.
Yang J; Fan Z; Yang J; Ding J; Yang C; Chen L
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231895
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor.
Chen J; Zhang J; Xu L; Xu C; Chen S; Yang J; Jiang H
Atherosclerosis; 2012 Oct; 224(2):332-9. PubMed ID: 22857898
[TBL] [Abstract][Full Text] [Related]
37. CYLD Deubiquitinates Nicotinamide Adenine Dinucleotide Phosphate Oxidase 4 Contributing to Adventitial Remodeling.
Yu B; Liu Z; Fu Y; Wang Y; Zhang L; Cai Z; Yu F; Wang X; Zhou J; Kong W
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1698-1709. PubMed ID: 28751569
[TBL] [Abstract][Full Text] [Related]
38. Hydrogen-rich saline prevents neointima formation after carotid balloon injury by suppressing ROS and the TNF-α/NF-κB pathway.
Qin ZX; Yu P; Qian DH; Song MB; Tan H; Yu Y; Li W; Wang H; Liu J; Wang Q; Sun XJ; Jiang H; Zhu JK; Lu W; Huang L
Atherosclerosis; 2012 Feb; 220(2):343-50. PubMed ID: 22153150
[TBL] [Abstract][Full Text] [Related]
39. Prion protein is required for tumor necrosis factor α (TNFα)-triggered nuclear factor κB (NF-κB) signaling and cytokine production.
Wu GR; Mu TC; Gao ZX; Wang J; Sy MS; Li CY
J Biol Chem; 2017 Nov; 292(46):18747-18759. PubMed ID: 28900035
[TBL] [Abstract][Full Text] [Related]
40. Regulation of the deubiquitinating enzyme CYLD by IkappaB kinase gamma-dependent phosphorylation.
Reiley W; Zhang M; Wu X; Granger E; Sun SC
Mol Cell Biol; 2005 May; 25(10):3886-95. PubMed ID: 15870263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
